How many investments has BayMed Venture Partners made?

BayMed Venture Partners has 12 tracked investments, 1 of which have exited.

What stage does BayMed Venture Partners invest at?

BayMed Venture Partners invests at the Pre-Seed, Seed, Series A, Series B stages.

What sectors does BayMed Venture Partners focus on?

BayMed Venture Partners focuses on Digital Health, Healthtech, Medical Devices.

Where is BayMed Venture Partners located?

BayMed Venture Partners is headquartered in San Francisco, US.

Who does BayMed Venture Partners co-invest with?

BayMed Venture Partners most often shares deals with Broadview Ventures, Arboretum Ventures, ARCH Venture Partners, among 22 tracked co-investors.

BayMed Venture Partners

Venture capital

San Francisco · Pre-Seed–Series B · 7 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into BayMed Venture Partners

272 people in our graph share verified history with the BayMed Venture Partners team — schools, employers, funds. One of them is your warm intro.

Jun Liunlockedknows Gary Gershony · together at Band of Angels (overlapped)

knows the team · via AtaCor Medical, Inc.

knows the team · via Lifescienceangels

×4knows the team · via University of Illinois Chicago

knows the team · via Partner Fund Management

×4knows the team · via Citadel LLC

✨ Fox Verdict

Investment thesis

BayMed Venture Partners focuses on maturing early-stage medical device and digital health companies in North America and Israel, targeting important unmet clinical needs with disruptive, differentiated innovation. The firm draws on deep clinical and operational expertise and cross-functional support to help portfolio companies succeed. It emphasizes global sourcing and deal flow through extensive industry relationships, and applies a results-driven, exit-focused methodology, acting as a true partner to companies to drive growth and value for portfolio companies, investment partners, and the broader healthcare system.

Invests inDigital Health Healthtech Medical Devices Israel North America San Francisco United States

Source: firm website, verified Aug 11, 2026.

Stage

Pre-Seed–Series B

San Francisco, CA, US

Instruments

Equity

Founded

2020

Tracked investments

Acquisitions

Team · 7 people

from the firm's website & public directories

Gary Gershony, MD· Founding General Partner

Dr. Gershony founded and served as Chief Medical Officer and board member for Vascular Solutions and AngioScore, acquired for a combined $1.3B. An interventional cardiologist and experienced healthcare venture and angel investor, he holds 11 patents and has led over 50 clinical trials with more than 100 peer-reviewed publications.

Gary Gershony· Founding General Partner· San Francisco, California, United Statesin

Dr. Gary Gershony is an interventional cardiologist who trained at the University of Toronto Medical School and completed a fellowship at Emory University; he has practiced at John Muir Health Cardiovascular Institute since 1999 and previously directed interventional cardiology at UC Davis from 1993 to 1997. He founded Vascular Solutions, which had an IPO in 2000, and co-founded AngioScore, acquired by Spectranetics in 2014, and holds 11 issued medical device patents. He is a founding General Partner of BayMed Venture Partners, a San Francisco venture capital firm focused on early-stage medical device and digital health companies in North America and Israel, and serves on the boards or advisory boards of several medical device companies.

g•••@baymedvp.comreveal

Neil Meyer· Founding General Partner· San Francisco Bay Areain

Neil has over 20 years in the healthcare sector as an investor at firms including Partner Fund Management, Citadel, and JPMorgan. He also led investor relations and strategic finance at Thoratec Corporation before its $3.4B acquisition by St. Jude Medical, and has served on boards of early-stage medical device companies.

n•••@baymedvp.comreveal

Amanda White· Senior Associate

Amanda has more than ten years of medical device industry experience, including seven years at Edwards Lifesciences on transcatheter delivery systems, and was a Stanford Biodesign Innovation Fellow. She served as an investment fellow with Life Science Angels and is currently Senior Manager of Clinical Engineering at NC8. She holds biomedical engineering and economics degrees from Duke University.

Gregg W. Stone, MD· Advisor and clinical key opinion leader

Dr. Stone is a globally recognized leader in medical device technology development, Director of the TCT symposium, and Professor of Medicine at Mount Sinai Heart Health System. He has been principal investigator on more than 120 randomized clinical trials.

Leslie Saxon, MD· Advisor and digital health key opinion leader

Dr. Saxon is Executive Director of the USC Center for Body Computing, a cardiac electrophysiologist, professor, and digital health expert with over 200 peer-reviewed publications. She is a frequent speaker at CES, TEDMED, and SXSW and a recipient of numerous awards.

Martin T. Rothman, MD· Advisor and industry key opinion leader

Dr. Rothman is the former Chief Medical Officer for cardiovascular at Medtronic, co-founder of the British Cardiovascular Intervention Society, and Professor of Interventional Cardiology at Barts Health in London. He is a named inventor on more than 140 patents and an experienced venture partner.

What they invest in

from 12 of 12 portfolio companies

Healthtech ×12Medical Devices ×9Digital Health ×4Hardware ×4Biotech ×3AI & Machine Learning ×1Deep Tech ×1Enterprise Software ×1

HQs:United States×5Israel×2

Investments · 12 tracked

founders shown can be your intro path

By year:2022 · 2 2018 · 1 2014 · 14 dated

Deep Bluedeepbluemedical.com in 𝕏✓ verified

Deep Blue Medical Advances develops surgical devices and solutions to improve abdominal surgical processes and patient outcomes.

HealthtechMedical Devices

Howard Levinson(Inventor/Founder, Chief Medical Officer, Director)

Co-investorsBand of Angels Duke Capital Partners Wolfpack Investor Network

Append Medicalappendmedical.com in

Append Medical develops a transcatheter system using vacuum-based technology to treat non-valvular atrial fibrillation by occluding the left atrial appendage without implanting a device in the heart.

Deep TechHealthtechMedical DevicesOr Yehuda, IL

Leonid Sternik(MD, Inventor and cardiac surgeon)Zachi Berger(Founder and Observer)in Nadav Agian(CEO)in

Co-investorsALIVE Israel HealthTech Fund Shoni Health Ventures

AtaCor Medicalatacor.com

AtaCor Medical develops extravascular lead systems for cardiac rhythm management, including a novel extravascular defibrillation lead for EV-ICD therapy and an implantable, extracardiac pacemaker.

HardwareHealthtechMedical Devices

Alan(Co-founder & Vice President of Clinical, Regulatory & Quality)

Co-investorsArboretum Ventures Broadview Ventures Catalyst Health Ventures Hatteras Venture Partners

Cardiosensecardiosense.com in 𝕏Nov 2022

Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management.

AI & Machine LearningDigital HealthHealthtechMedical DevicesChicago, US

Omer Inan(Co-founder, Chief Scientific Officer)in Andrew Carek(Co-founder, Chief Technical Officer)in Amit Gupta(Co-founder, Advisor)inMozziyar Etemadi(Co-founder, Head of AI)Omer Inan, PhD(Co-founder, Chief Scientific Officer)in Andrew Carek, PhD(Co-founder, Chief Technical Officer)in

Co-investorsBroadview Ventures Cross-Border Impact Ventures Laerdal Million Lives Fund OSF Ventures Portal Innovations Hatteras Venture Partners

Embolxembolx.com in 𝕏Oct 2022

Embolx is a commercial-stage medical device company developing microcatheters for arterial embolization procedures used to treat conditions such as cancerous tumors, benign prostatic hyperplasia, and uterine fibroids.

HardwareHealthtechMedical DevicesSunnyvale, US

Robert J.J. de Neve(Executive Officer, Director)Michael Allen(President & CEO)inNORMAN GITIS(Director)Paul Rogan(Director)FRANK GRILLO(Director)inTIANHONG XU(Director)

First Light Diagnosticsfirstlightdx.com in 𝕏

First Light Diagnostics develops the MultiPath benchtop analyzer, an instrument for rapid diagnostic testing.

BiotechHealthtechMedical Devices

Co-investorsBoston Harbor Angels LRVHealth

Hillromhillrom.com in

Hillrom, now part of Baxter, develops connected medical devices and clinical systems for hospitals, physician offices, pharmacies and home care, including smart beds, vital signs monitors, infusion pumps, nurse call and communication systems, diagnostic and examination tools, respiratory and surgical technologies, and pharmaceuticals.

Digital HealthHealthtechMedical Devices

Landmark Healthlandmarkhealth.org

Optum Care at Home provides in-home medical care and care navigation services for people enrolled in eligible health plans, including yearly in-home health visits, health screenings, and coordination of benefits like transportation and food assistance.

Digital HealthHealthtechHuntington Beach, US

Michael Huy Le, M.D.(Executive Officer)Adam Boehler(Executive Officer, Director)Eric Van Horn(Executive Officer)Elizabeth Haughton(Executive Officer)Carol De Vol(Executive Officer)Theodore Halkias(Executive Officer)

Co-investorsKhosla Ventures

Thermo Fisher Scientificthermofisher.com in 𝕏Feb 2014Acquired

Thermo Fisher provides life science products and laboratory equipment, including antibodies, consumables, biobanking resources, and Cryo-EM imaging systems for research labs and scientists.

BiotechEnterprise SoftwareHardwareHealthtechWaltham, US

Anthony Uzzo(Executive Officer, Director)inJoshua Geballe(Executive Officer, Director)James Gregory(Executive Officer, Director)Marc N. Casper(Executive Officer, Director)inAndrew J. Thomson(Executive Officer)Peter M. Wilver(Executive Officer)

Co-investorsARCH Venture Partners Cross Creek Advisors Excel Venture Management Heran Partners Oak HC/FT Domain Associates +2 more

Trisol Medicaltrisol-medical.com in

Trisol Medical develops a transcatheter tricuspid valve replacement device, using a nitinol frame with a dome-shaped leaflet, to treat severe tricuspid regurgitation while preserving right ventricle function.

HardwareHealthtechMedical DevicesYokneam, IL

Mordehay Vaturi(Inventor & Medical Director)inRon Davidson(CEO)inEli Ben-Hamou(VP R&D)Anat Kaufman(VP Regulatory)in

BoardShimon Eckhouse(Chairman)

Valfixmedvalfixmed.comAug 2018

VALFIX develops a transcatheter mitral valve repair system with a robotic interface, designed to convert open-heart valve surgery into a minimally invasive transcatheter procedure.

BiotechHealthtechMedical DevicesRoboticsTel Aviv-Yafo

Philip Lavin(Director)Elad Yaacoby(Director)Eli Bar(Executive Officer, Director)

Board Gary Gershony(Director)in

Vitaltechvitaltech.com in 𝕏

VitalTech develops solutions for virtual care delivery that optimize performance across the healthcare continuum for clients and their patients.

Digital HealthHealthtechSaaS

Co-investorsStanley Ventures

Portfolio news

latest coverage across their companies

Thermo Fisher Scientific stock hits 52-week high at 647.72 USD By Investing.com

Thermo Fisher Scientific · investing.com · Sep 16, 2026

Trysignalbase

Deep Blue · trysignalbase.com · Apr 22, 2026

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease - Hatteras

Cardiosense · hatterasvp.com · Jan 9, 2026

Frequently asked questions

How many investments has BayMed Venture Partners made?: BayMed Venture Partners has 12 tracked investments, 1 of which have exited.
What stage does BayMed Venture Partners invest at?: BayMed Venture Partners invests at the Pre-Seed, Seed, Series A, Series B stages.
What sectors does BayMed Venture Partners focus on?: BayMed Venture Partners focuses on Digital Health, Healthtech, Medical Devices.
Where is BayMed Venture Partners located?: BayMed Venture Partners is headquartered in San Francisco, US.
Who does BayMed Venture Partners co-invest with?: BayMed Venture Partners most often shares deals with Broadview Ventures, Arboretum Ventures, ARCH Venture Partners, among 22 tracked co-investors.

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.

$50K – $12.7M

Kfund

Kfund is a venture capital firm that invests in entrepreneurs building differentiated technology-based products and services.

$108K – $10.8M

Flare Capital Partners

Flare Capital Partners is a healthcare technology-focused venture firm that partners with founders building companies to improve outcomes, lower costs, and reshape healthcare delivery.

$1M – $10M

Novartis Venture Fund

The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.

$5M – $25M

Equitage Ventures, L.L.C.

Equitage Ventures is an early-stage investor providing capital, distribution, and strategic guidance to entrepreneurs addressing the physical, mental, spiritual, and social needs of older adults across the senior care continuum.

$250K – $2.5M